Madrigal Pharmaceuticals, Inc. (MDGL)

NASDAQ: MDGL · Real-Time Price · USD

432.00

-13.85 (-3.11%)

At close: Feb 27, 2026, 4:00 PM EST

432.56

+0.56 (0.13%)

After-hours: Feb 27, 2026, 5:58 PM EST

Madrigal Pharmaceuticals Market Cap

Madrigal Pharmaceuticals has a market cap or net worth of $9.91 billion as of February 27, 2026. Its market cap has increased by 33.57% in one year.

Market Cap

9.91B

Enterprise Value

9.27B

1-Year Change

33.57%

Ranking

#943

Market Cap Chart

Since February 6, 2007, Madrigal Pharmaceuticals's market cap has increased from $297.50M to $9.91B, an increase of 3,231.11%. That is a compound annual growth rate of 20.18%.

Market Cap History

Date	Market Cap	% Change
Feb 27, 2026	9.91B	-25.07%
Dec 31, 2025	13.23B	96.52%
Dec 31, 2024	6.73B	47.33%
Dec 29, 2023	4.57B	-7.98%
Dec 30, 2022	4.96B	242.65%
Dec 31, 2021	1.45B	-15.74%
Dec 31, 2020	1.72B	22.31%
Dec 31, 2019	1.41B	-18.98%
Dec 31, 2018	1.74B	51.27%
Dec 29, 2017	1.15B	565.31%
Dec 30, 2016	172.40M	255.46%
Dec 31, 2015	48.50M	-83.19%
Dec 31, 2014	288.60M	-20.30%
Dec 31, 2013	362.10M	-35.14%
Dec 31, 2012	558.30M	141.48%
Dec 30, 2011	231.20M	-6.85%
Dec 31, 2010	248.20M	44.39%
Dec 31, 2009	171.90M	-17.20%
Dec 31, 2008	207.60M	-8.55%
Dec 31, 2007	227.00M	-23.70%

View and export this data all the way back to 2007. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BioMarin Pharmaceutical	11.87B
Jazz Pharmaceuticals	11.70B
Exelixis	11.44B
Avidity Biosciences	11.30B
ImmunityBio	10.05B
ABIVAX Société Anonyme	9.44B
Praxis Precision Medicines	9.38B
Bio-Techne	9.23B

Market Cap Rankings